Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Keane Insider Profile
11 Followers
Robert Keane, CEO, Chairman, Director at Cimpress, holds 2.19M shares in Cimpress (Ticker: CMPR), holds 736.23K shares in Astronics (Ticker: ATRO).
Profitable Transactions
11 out of 19 Profitable Transactions
Average Return
+21.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Keane holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Keane
Robert Keane's Trading History
Cimpress
Nov 19, 2024
CEO, Chairman, Director
Uninformative Buy
435.16K
$177.84M
Astronics
Aug 26, 2024
Director
Uninformative Buy
126.35K
$12.68M
List of latest transactions for each holding click on a transaction to see Robert Keane's performance on stock
You May Also Like
Robert Keane insider profile FAQ
What is the percentage of profitable transactions made by Robert Keane?
The percentage of profitable transactions made by Robert Keane is 58%.
What is the average return per transaction made by Robert Keane?
The average return per transaction made by Robert Keane is 21.60%.
What stocks does Robert Keane hold?
Robert Keane holds: CMPR, ATRO stocks.
What was Robert Keane’s latest transaction?
Robert Keane latest transaction was an Uninformative Buy of $435.16K.
What was Robert Keane's most profitable transaction?
Robert Keane’s most profitable transaction was an Informative Buy of CMPR stock on February 16, 2023. The return on the trade was 146.70%.
What is Robert Keane's role in Cimpress?
Robert Keane's role in Cimpress is CEO, Chairman, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.